Biotech startups that raised Series C in Shanghai, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| GRIT Biotechnology | Shanghai | Series C | $84.0M | 2025-10-14 |
| Convalife Pharmaceuticals | Shanghai | Series C | $14.1M | 2023-12-29 |
2 rows of the CSV in 5 of its 18 columns.
- The 29 biotech startups in Shanghai, China whose last round is Series C have raised $1.5B in total.
- 1 of them closed their most recent round in the last 12 months, $40.0M combined.
- The largest of those rounds is Yudao Bio's $40.0M Series C, dated September 2026.
- Health care is the most common other sector, with 25 companies (86%).
- 0% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 51 to 100 employees (31% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
1 of 29| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| GRIT Biotechnology | GRIT Biotechnology develops tumor infiltrating lymphocyte immunotherapy for solid tumors. | Biotech | Series C | $84.0M | 2025-10-14 | $153.5M | Matrix Partners China, Hillhouse Investment, CICC +2 | 51 to 100 | 2019 |
Table 1. Biotech startups that raised Series C in Shanghai, China: the 1 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 29.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Matrix Partners China | Venture capital firm | Beijing, China | 1 | 3% | ||
| 2 | Sherpa Healthcare Partners | Venture capital firm | Beijing, China | 1 | 3% | ||
| 3 | CICC | Investment bank | Beijing, China | 1 | 3% | ||
| 4 | Hillhouse Investment | Angel group | Singapore | 1 | 3% | ||
| 5 | Decheng Capital | Venture capital firm | Menlo Park, United States | 1 | 3% | ||
| 6 | Wuxi New District Investment Group | Venture capital firm | Wuxi Shi, China | 1 | 3% | ||
| 7 | Legend Capital | Venture capital firm | Beijing, China | 1 | 3% | ||
| 8 | Lucion | Venture capital firm | Jinan, China | 1 | 3% | ||
| 9 | GF Xinde Investment Management | Private equity firm | Guangzhou, China | 1 | 3% | ||
| 10 | Xicheng Zhiyuan | Private equity firm | Xicheng, China | 1 | 3% | ||
| 11 | Shangyu Hangzhou Bay Economic Development Zone Holding Group | Shaoxing, China | 1 | 3% | |||
| 12 | GGV Capital | Venture capital firm | Menlo Park, United States | 1 | 3% | ||
| 13 | Tianjin Venture Capital | Venture capital firm | Tianjin, China | 1 | 3% |
Table 2. Biotech startups that raised Series C in Shanghai, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 25 | 86% | $1.4B |
| Hardware | 1 | 3% |
Table 3. Biotech startups that raised Series C in Shanghai, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 29 | 100% | $50.0M |
Table 4. Biotech startups that raised Series C in Shanghai, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 100% | $40.0M |
Table 5. Biotech startups that raised Series C in Shanghai, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 1 | 3% | $40.0M |
| 2025 | 4 | 14% | $207.1M |
| 2024 | 1 | 3% | |
| 2023 | 3 | 10% | $57.3M |
| 2022 | 3 | 10% | $30.6M |
| 2021 | 9 | 31% | $488.7M |
Table 6. Biotech startups that raised Series C in Shanghai, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2015 to 2019 | 17 | 59% |
| 2010 to 2014 | 4 | 14% |
| Before 2010 | 8 | 28% |
Table 7. Biotech startups that raised Series C in Shanghai, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 2 | 7% |
| 11 to 50 | 5 | 17% |
| 51 to 100 | 9 | 31% |
| 101 to 250 | 8 | 28% |
| 251 to 500 | 1 | 3% |
| 501 to 1,000 | 4 | 14% |
Table 8. Biotech startups that raised Series C in Shanghai, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series C and its headquarters is in Shanghai, China. On 16 November 2026 that is 29 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 1 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 29 rows: 7 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Shanghai, China whose last round is Series C are on the list?
- 29, in the file dated 16 November 2026. 1 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 29 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 2 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.